The reversible inhibitory effects of nitric oxide (⅐NO) on mitochondrial cytochrome oxidase and O 2 uptake are dependent on intramitochondrial ⅐NO utilization. This study was aimed at establishing the mitochondrial pathways for In the early 1970s, it was recognized that isolated respiring mitochondria produce hydrogen peroxide (H 2 O 2 ) at rates that depend on the redox state of the components of the respiratory chain and, consequently, on the mitochondrial metabolic state and the presence of inhibitors (1, 2). Mitochondrial production of H 2 O 2 accounts for about 1% of the O 2 uptake under physiological conditions, according to evidence obtained from perfused rat liver and heart (3). Mitochondrial H 2 O 2 is produced through the manganese-superoxide dismutase-catalyzed disproportionation of O 2
In the early 1970s, it was recognized that isolated respiring mitochondria produce hydrogen peroxide (H 2 O 2 ) at rates that depend on the redox state of the components of the respiratory chain and, consequently, on the mitochondrial metabolic state and the presence of inhibitors (1, 2) . Mitochondrial production of H 2 O 2 accounts for about 1% of the O 2 uptake under physiological conditions, according to evidence obtained from perfused rat liver and heart (3). Mitochondrial H 2 O 2 is produced through the manganese-superoxide dismutase-catalyzed disproportionation of O 2 . (4 -6), which is vectorially generated into the mitochondrial matrix during ubisemiquinone autoxidation (4, 7, 8) and NADH-dehydrogenase activity (9) . The relatively high rate of O 2 . production in the mitochondrial inner membrane is in a functional relationship with the localization of superoxide dismutase in the mitochondrial matrix, which keeps a compartmentalized low steady-state concentration of
. ] ss ). Based on the rate of production of O 2 . , the content of manganese-superoxide dismutase in the mitochondrial matrix, and the corresponding second order rate constants, a [O 2 . ] ss value of 0.5-1.0 ϫ 10 -10 M can be estimated (3, 10) . Nitric oxide (⅐NO) produced by the endothelium elicits cellular physiological effects within a wide concentration range (10 -9 to 10 -5 M). The effects of ⅐NO on mitochondria-inhibition of cytochrome c oxidase (11) (12) (13) (14) (15) (16) (17) (18) (19) , impairment of electron flow at the cytochrome bc 1 region (17) , and oxidation of ubiquinol (20, 21) -require progressively increasing concentrations of this species. ⅐NO regulates O 2 uptake and promotes H 2 O 2 release by mitochondria (17, 22) (an effect also demonstrated in the isolated beating rat heart (23)); the increase in mitochondrial H 2 O 2 formation may be understood as an antimycin-like effect of ⅐NO accomplished by its effective binding to the cytochrome bc 1 segment (17) .
The ⅐NO influx in the mitochondrial compartment is expected to affect the steady-state levels of O 2 . due to the diffusion-controlled reaction between these species (24, 25) to yield peroxynitrite (ONOO -) (26) . Three recently recognized facts add complexity to the mitochondrial interactions between O 2 .
and ⅐NO: first, ⅐NO inhibits succinate-cytochrome c reductase activity and increases O 2 . production in submitochondrial particles, isolated mitochondria, and perfused rat heart (17, 23) . Second, membrane-bound mitochondrial NOS 1 generates ⅐NO at rates that are similar to the rates of mitochondrial O 2 . production (27) (28) (29) . Third, ⅐NO can be reduced to the nitroxyl anion (NO -) by one-electron transfers from three reduced components of the mitochondrial respiratory chain: ubiquinol, cytochrome c, and cytochrome c oxidase (20, 30, 31) .
The fine metabolic control of the intramitochondrial steadystate concentrations of ⅐NO-performed through a series of oxidative and reductive reactions involving O 2 . , ubiquinol, the cytochrome bc 1 segment, and cytochrome c oxidase-is relevant to mitochondrial physiology with further implications for cell energy production. This study is aimed at establishing the mitochondrial pathways for ⅐NO utilization that regulate O 2 .
generation via reductive and oxidative reactions involving ubiquinol and ONOO -, respectively. For this purpose, experimental models consisting of ubiquinone-depleted/reconstituted submitochondrial particles and ONOO --supplemented submitochondrial particles were used.
MATERIALS AND METHODS
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§ To whom correspondence should be addressed. Tel. and Fax: 54-114-508-3983; E-mail: jpoderos@fmed.uba.ar. bovine serum albumin, NaBH 4 , ubiquinone-0 (UQ 0 ) (2,3-dimethoxy-6-methyl-1,4-benzoquinone), ubiquinone-10 (UQ 2 ) (decylubiquinone), and ubiquinone-50 (UQ 10 ) were from Sigma. DETANO was from Alexis Corp. (San Diego, CA). Ubiquinone reduction was carried out prior to the onset of the experiment upon addition of 10 -20 l of NaBH 4 (20 mM solution in 0.1 N NaOH) to 3 ml of 20 mM quinones dissolved in either water (UQ 0 ) or in ethanol (UQ 2 ); ubiquinone solutions were purged with argon for 5 min in a flask sealed with a rubber septum; the excess of reductant was eliminated by adding HCl up to 80 mM. Nitric oxide solutions (1.2-1.8 mM) were obtained by bubbling ⅐NO gas (99.9% purity; AGA GAS Inc., Maumee, OH) in helium-purged water for 30 min at room temperature; NO solutions were stocked at 4°C. All other reagents were of analytical grade.
Isolation of Rat Liver Mitochondria-Excised livers (mean weight, 10 g) from adult Harlan Sprague-Dawley female rats (200 -250 g) were placed in an ice-cold homogenization medium consisting of 0.23 M mannitol, 70 mM sucrose, 10 mM Tris-HCl, and 1 mM EDTA with 0.5% bovine serum albumin (pH 7.4). The tissue was finely minced and transferred to a motorized Teflon Potter-Elvejhem homogenizer (Thomas Scientific, Philadelphia, PA) and homogenized in 9 ml of cold homogenization medium per g of tissue. The homogenate was centrifuged at 700 ϫ g for 10 min. The supernatant was centrifuged at 7000 ϫ g for 10 min. The pellet was washed twice and resuspended in homogenization medium without bovine serum albumin at a protein concentration of 20 mg/ml. All procedures were performed at 4°C.
Preparation of Submitochondrial Particles-Submitochondrial particles were prepared from frozen and thawed mitochondria (20 mg of mitochondrial protein/ml) disrupted by sonication for three 10-s periods with 30-s intervals at an output of 40 W using a model W-225 sonifier (Heat Systems/Ultrasonics, Chicago, IL). Submitochondrial particles were washed twice and resuspended in the homogenization medium described above. All procedures were carried out at 4°C.
Preparation of Ubiquinone-depleted Submitochondrial ParticlesUbiquinone-depleted and reconstituted submitochondrial particles were prepared essentially as described previously (7) with minor modifications. Submitochondrial particles were resuspended in 0.15 M KCl at a concentration of 20 mg of protein/ml and lyophilized for 9 h to completely dehydrate the samples. Mitochondrial ubiquinone was removed by suspending the lyophilizate in n-pentane by gentle homogenizations. Extracted ubiquinone was 4 -5 nmol/mg of protein. Reincorporation of ubiquinone into submitochondrial particles was accomplished by resuspending the ubiquinone-depleted particles in a small volume of n-pentane (1-2 ml) containing UQ 10 at a concentration of 50 -100 nmol/mg of protein; the suspension was shaken in an iced bath for 30 min. The particles were centrifuged, dried by evaporation for 1 h, and stored. UQ 10 content of ubiquinone-reconstituted particles (5-40 nmol/mg of mitochondrial protein) was determined by high pressure liquid chromatography with electrochemical detection using an amperometric detector (Bioanalytical Systems, West Lafayatte, IN).
Mitochondrial Mitochondrial Transmembrane Potential-Mitochondrial membrane potential was measured fluorometrically with exc and em values of 503 and 527 nm, respectively (Hitachi Fluorometer model F200, Hitachi Ltd., Tokyo, Japan). The reaction mixture consisted of 0.25 mg of mitochondrial protein/ml in the respiratory medium described above supplemented with 0.2 M rhodamine 123 (33) . Complete polarization of the membrane was achieved by addition of 6 mM succinate and depolarization by pulses of ⅐NO.
Electron Paramagnetic Resonance-Electron paramagnetic resonance spectra were recorded on a Bruker ECS 106 equipped with a TM 8810 microwave cavity (Bruker Analytik GmbH, Rheinstetten, Germany). Measurements were carried out at room temperature at a microwave frequency of 9.80 GHz and 100 kHz field modulation. Other instrument settings were as described in the figure legends.
Determination of Nitric Oxide-⅐NO was determined amperometrically with an electrode ISO-NO (World Precision Instruments, Sarasota, FL) in 3 ml of respiration medium (see above) with electromagnetic stirring at 30°C. The ⅐NO electrode was calibrated daily with NaNO 2 in acid medium (0.1 M H 2 SO 4 -KI) to generate known concentrations of ⅐NO.
Absorption Spectroscopy-Absorption spectra of ubiquinones were obtained with a Hitachi U-3000 spectrophotometer (Hitachi Ltd., Tokyo, Japan) from submitochondrial particles supplemented with 40 M UQ 0 and 1 mM KCN in 50 mM H 2 NaPO 4 /HNa 2 PO 4 , pH 7.4. For the anaerobic experiments, the reaction medium was deoxygenated by bubbling argon during 30 min and placed in 1 ml quartz cuvettes. The cuvettes were sealed with a rubber septum and an aliquot of a ⅐NO solution was injected into the cuvette with a gas-tight syringe (final concentration, 30 M ⅐NO). The spectral changes were recorded in the UV region; increase in absorbance at 266 nm indicated the oxidation of ubiquinol to ubiquinone (⑀ 266 ϭ 14.2 mM -1 cm -1 ). Mitochondrial H 2 O 2 Production-H 2 O 2 production was continuously monitored by the horseradish peroxidase/p-hydroxyphenyl acetic acid assay in the Hitachi F-2000 spectrofluorometer (Hitachi Ltd., Tokyo, Japan) with excitation and emission wavelengths at 315 and 425 nm, respectively (34) . The reaction mixture consisted of the respiratory medium described above supplemented with 8 mM succinate, 12 units/ml horseradish peroxidase, 50 M p-hydroxyphenyl acetic acid, and 0.1-0.5 mg of mitochondrial protein/ml.
Mitochondrial O 2 . Production-O 2 . production by liver submitochondrial particles was measured by superoxide dismutase-sensitive cytochrome c reduction at 550 nm (⑀ 550 ϭ 21 mM -1 cm -1 ) in a reaction mixture consisting of respiratory medium supplemented with, 1 mM succinate, 10 M cytochrome c, 2.4 M myxothiazol, 1 mM cyanide, and 0.1 mg of mitochondrial protein/ml in the presence or absence of 10 nM superoxide dismutase (7) .
Cytochrome Oxidase Activity-This activity was determined by monitoring the oxidation of 50 M of reduced cytochrome c in a Hitachi U-3000 spectrophotometer at 550 nm (⑀ 550 ϭ 21 mM -1 cm -1 ). Cytochrome c was reduced with potassium ascorbate followed by 24 h dialysis against 10 mM Na 2 HPO 4 /KH 2 PO 4 , pH 7.2. The rate of cytochrome c oxidation was determined as the pseudo-first order constant reaction (kЈ) and expressed as kЈ(min -1 ) mg protein -1 . Activity of Manganese-superoxide Dismutase-Manganese-superoxide dismutase was determined spectrophotometrically by inhibition of the rate of cytochrome c reduction (followed at 550 nm). The reaction mixture consisted of 20 M cytochrome c, 0.5 mM xanthine, and xanthine oxidase in 50 mM potassium phosphate/0.1 mM EDTA, pH 7.8 (35). 1 mM NaCN was used to inhibit copper-zinc-superoxide dismutase and cytochrome c oxidase activities.
Mitochondrial Protein Determination-Protein concentration was determined by the Lowry assay using bovine serum albumin as standard.
Data Analysis-Data shown in figures express mean values from duplicate determinations.
RESULTS
Effects of ⅐NO on Mitochondrial Respiration-⅐NO utilization
by liver mitochondria is evidenced by the first order decay of the ⅐NO signal with a t1 ⁄2 of 1.8 min (Fig. 1A, a) . The initial rate of ⅐NO decay was linearly related to mitochondrial protein concentration (Fig. 1B, a) , thus indicating the involvement of mitochondrial components in the pathway(s) for ⅐NO decay. From the plot in Fig. 1B , a, a rate of utilization of ⅐NO by mitochondria of 1 nmol/min/mg of protein may be calculated. ⅐NO elicited a complete and transient inhibition of mitochondrial O 2 uptake in state 3; respiration restarted when ⅐NO levels decreased to ϳ0.35 M (Fig. 1A, b) . Half-maximal inhibition of O 2 uptake in state 3 was observed at 0.17 M ⅐NO (Fig.  1B, b) . ⅐NO decreased the mitochondrial membrane potential as detected by changes in rhodamine fluorescence (33) (Fig. 1A, c) ; half-maximal inhibition of membrane potential was observed at about 0.15 M ⅐NO (Fig. 1B, c) .
Mitochondrial Pathways for ⅐NO Utilization- Fig. 2 shows the time courses of ⅐NO decay in the presence of rat liver submitochondrial particles under anaerobic and aerobic conditions. In anaerobiosis, ⅐NO metabolism is expected to be encompassed mainly by reductive pathways, i.e. the reduction of ⅐NO to the nitroxyl anion (NO -), as follows.
This reaction involves different electron donors. In this context, ubiquinol (Reaction 2) (20), cytochrome c (Reaction 3) (30), and cytochrome oxidase (Reaction 4) (31) were reported to facilitate the redox transition depicted in Reaction 1 (cyt c is cytochrome c).
Under anaerobic conditions, the rate of ⅐NO decay in the presence of submitochondrial particles supplemented with succinate and the inhibitor myxothiazol (which inhibits electron flow between cytochromes b and c) was ϳ0.1 nmol/min/mg of protein ( Fig. 2A, trace b) ; this rate increased to ϳ0.14 nmol/ min/mg of protein in the absence of myxothiazol ( Fig. 2A , trace c). In the former instances, ubiquinol is the likely electron donor for Reaction 1; the rate constant of this reaction may be estimated as 2.1 ϫ 10 3 M -1 s -1 based on an ubiquinol content of ϳ2 nmol/mg of mitochondrial protein under these experimental conditions (36) . In the latter instances-in absence of myxothiazol-reduction of cytochrome c (Reaction 3) and cytochrome oxidase (Reaction 4) also contribute to ⅐NO decay via a reductive pathway.
Under aerobic conditions and in the absence of submitochondrial particles, ⅐NO decay followed as a pseudo-first order process with a t1 ⁄2 of 6 min ( (The t1 ⁄2 corresponding to a ⅐NO concentration of 0.1 M in tissues with ϳ20 M O 2 determined by this nonenzymatic reaction would be 8.6 -23 h (37) and, hence, biologically negligible.) Succinate-supplemented submitochondrial particles decreased the t1 ⁄2 of ⅐NO decay to 1.7 min (Fig. 2B, trace b) . This t1 ⁄2 value was decreased and increased by UQ 0 (Fig. 2B , trace c) and superoxide dismutase (Fig. 2B , trace d) (1.2 and 2.6 min, respectively). The effect elicited by superoxide dismutase suggests a role for O 2 . in the decay pathways of ⅐NO, as follows.
The rates of ⅐NO utilization by rat liver submitochondrial particles under aerobic conditions were linearly dependent on ⅐NO concentrations in the 0.025-0.4 M range and, consequently, followed first order kinetics (Fig. 3) . From the plots in Fig. 3A , the rates of ⅐NO utilization by mitochondria under different conditions may be calculated: ⅐NO utilization by succinate-supplemented submitochondrial particles proceeded at rates of ϳ0.3-0.5 nmol/min/mg of protein (when supplemented with 50 -100 nM ⅐NO). In the presence of superoxide dismutase, ⅐NO utilization by submitochondrial particles proceeded in a O 2 .
-independent fashion at rates of 0. ubiquinone and reconstituted with variable amounts of ubiquinones showed a linear relationship between quinone content and H 2 O 2 formation (7). Succinate-dependent H 2 O 2 production in ubiquinone-depleted and ubiquinone-reconstituted membranes was linearly related to the ubiquinone content over a wide range of quinone levels (up to 26 nmol/mg of protein). Thus, ubiquinone autoxidation appears to be a major source of H 2 O 2 production (via O 2 . disproportionation) under conditions that involve inhibition of electron transport between cytochromes b and c (e.g. in the presence of antimycin A or myxothiazol) (7). The roles of nitric oxide and ubiquinol content in mitochondrial membranes in the production of H 2 O 2 were assessed with two experimental models: ubiquinone-depleted submitochondrial particles in the absence of inhibitors of the electron transport chain (e.g. myxothiazol) and submitochondrial particles with an expanded ubiquinol pool in the presence of myxothiazol.
In the absence of myxothiazol, succinate-supplemented submitochondrial particles show negligible production of H 2 O 2 (Fig. 4A) ; the addition of ⅐NO slightly enhances H 2 O 2 production under these conditions. Reconstitution of these mitochondrial membranes with variable amounts of ubiquinone results in increasing H 2 O 2 production with increasing ⅐NO concentrations up to 0.25 M. Beyond this ⅐NO concentration, only slight increases of H 2 O 2 formation were observed (Fig. 4A ). Both ⅐NO utilization and H 2 O 2 production by succinate-supplemented, ubiquinone-depleted submitochondrial particles were linearly dependent on the amount of ubiquinone (UQ 10 ) added (Fig. 4B) .
These experiments suggest that, first, ubiquinone is essential for the production of H 2 O 2 by mitochondrial membranes and, second, that ⅐NO (in the absence of myxothiazol) may elicit two effects in a concentration-dependent manner: on the one hand, ⅐NO inhibits electron flow at the cytochrome bc 1 segment (17) (analogous to the effects of antimycin A and myxothiazol) and, on the other hand, ⅐NO oxidizes ubiquinol (Reaction 2) (20), thus triggering ubisemiquinone autoxidation (Reaction 6; k 6 ϭ 8 ϫ 10 are strengthened by experiments carried out with submitochondrial particles with an intact ubiquinone content and in which the ubiquinone pool was expanded upon addition of Q 0 or Q 2 ( Fig. 4C ): under these conditions and with a fixed concentration of ⅐NO, the production of H 2 O 2 increases with increasing supplementation of the particles with either quinone.
Intact submitochondrial particles supplemented with UQ 0 show a succinate-ubiquinone reductase activity of about 70 nmol/min/mg of protein in the presence of myxothiazol (Fig.  4D) ; addition of ⅐NO results in oxidation of the formed UQ 0 H 2 at a rate of ϳ24 nmol/min/mg of protein (Fig. 4D) . The latter rate reflects only partially the ubiquinol oxidation by ⅐NO because of concomitant reduction of the quinone by succinate dehydrogenase.
Taken together, these experimental models suggest that H 2 O 2 formation by mitochondrial membranes requires ubisemiquinone autoxidation accomplished in a sequential manner by, on the one hand, increasing the ubiquinol pool by impairing electron flow at the bc 1 segment and, on the other hand, increasing ubiquinol oxidation by ⅐NO (Reaction 2).
⅐NO A solution of ⅐NO in air-saturated respiratory medium without further addition (E), with submitochondrial particles (q), with submitochondrial particles plus succinate (f), with submitochondrial particles plus succinate and UQ 0 (OE), and with submitochondrial particles plus succinate and superoxide dismutase (Ⅺ). Concentrations of reactants were as in Fig. 2B . B, dependence of the rate of ⅐NO utilization on ⅐NO concentration. Assay conditions were as in A with varying amounts of ⅐NO. *, the units for these values (E) are M/min (assay carried out in the absence of submitochondrial particles).
FIG. 4.
Dependence of H 2 O 2 production and ⅐NO utilization by submitochondrial particles on ubiquinone concentration. A, ⅐NO-induced H 2 O 2 production by ubiquinone-depleted submitochondrial particles. Assay conditions: ubiquinone-depleted or ubiquinonerestored submitochondrial particles in respiration medium were supplemented with 6 mM succinate and varying amounts of ⅐NO. f, ubiquinone-depleted submitochondrial particles. Ⅺ, q, and E, ubiquinone-depleted submitochondrial particles supplemented with 5-, 10-, and 20 nmol of UQ 10 /mg of protein, respectively. B, dependence of the rates of ⅐NO utilization and H 2 O 2 production on UQ 10 content. Assay conditions: ubiquinone-depleted/reconstituted submitochondrial particles in respiration medium were supplemented with 6 mM succinate and 1 M ⅐NO and different amounts of UQ 10 . C, effect of ubiquinones on H 2 O 2 formation by submitochondrial particles. Assay conditions: 0.12 mg of submitochondrial particle protein/ml in respiration medium were supplemented with 5 M ⅐NO and different amounts of UQ 0 or UQ 2 . D, succinate-ubiquinone reductase activity of submitochondrial particles. The absorption spectrum was obtained in anaerobiosis from a reaction mixture consisting of submitochondrial particles (0.025 mg of protein/ ml) in respiration medium supplemented with 45 M UQ 0 and 2.4 M myxothiazol (spectrum a). The reaction was initiated upon addition of 6 mM succinate, which resulted in a reduction of ubiquinone (decrease of absorbance) (downward arrow; spectra b-i). Addition of ⅐NO (40 M) under the conditions of spectrum i resulted in ubiquinol oxidation (upward arrow).
performed with intact mitochondria (Fig. 1A, b) , ⅐NO also inhibits temporarily O 2 consumption by submitochondrial particles. The role of ubiquinol in the ⅐NO-inhibitable respiration was assessed with three experimental designs, as follows.
(a) O 2 uptake was measured in ubiquinone-depleted/reconstituted submitochondrial particles (Fig. 5A ). In these instances, the period of inhibition of O 2 uptake elicited by ⅐NO (until respiration was restored) was decreased with increasing concentrations of UQ 10 incorporated into the membranes (UQ 10 reincorporated was measured as succinate-reducible ubiquinone, thus indicating that reincorporation took place at specific sites in the respiratory chain critical for electron transfer). Half-maximal inhibitory effect was obtained with 15 nmol of UQ 10 /mg of protein.
(b) Cytochrome oxidase activity was measured in ubiquinone-depleted/reconstituted submitochondrial particles with a myxothiazol-inhibited electron flow and supplemented with reduced cytochrome c (Fig. 5B) . Under these conditions, the activity of cytochrome oxidase was measured as cytochrome c oxidation. As described above, the period of inhibition of cytochrome c oxidation exerted by nitric oxide was decreased with increasing concentrations of UQ 10 incorporated into the mitochondrial membranes.
(c) Cytochrome oxidase activity was measured in submitochondrial particles with an increased ubiquinol pool (accomplished by supplementation with increasing concentrations of UQ 0 and UQ 2 ) and in the presence of myxothiazol (Fig. 5C) . Similar to the results described above, this resulted in a decrease of the time of inhibition of cytochrome oxidase activity by ⅐NO. Half-maximal inhibitory effects were obtained with 20 and 50 M UQ 0 and UQ 2 , respectively.
These experimental approaches strongly suggest the occurrence of independent pathways for ⅐NO utilization in mitochondria, which effectively compete with the binding of ⅐NO to cytochrome oxidase, thereby releasing this inhibition and restoring O 2 uptake. Hence, in these experimental models, the ubiquinone-dependent decrease of the temporary inhibition of O 2 uptake elicited by ⅐NO may be understood as a competition between cytochrome oxidase (Reaction 4), ubiquinol (Reaction 2), and O 2 . (Reaction 5) for ⅐NO, regardless of whether the succinate oxidase activity was inhibited or not by myxothiazol. This is illustrated by the decrease in the inhibition time of cytochrome oxidase by increasing ubiquinone concentrations under conditions in which electron transfer is blocked by myxothiazol (Fig. 5B) . The significance of Reaction 5 for the mitochondrial pathways of ⅐NO utilization is suggested by the increase in cytochrome oxidase inhibition time by superoxide dismutase (Fig.  5D ) in experiments in which the ubiquinone pool of submitochondrial particles was augmented by addition of UQ 0 . An alternative reductive pathway for ⅐NO may be its reaction with reduced cytochrome c (Reaction 3) (30), although the contribution of this reaction to the intramitochondrial decay rate of ⅐NO is uncertain, because it probably occurs on the C phase of the inner mitochondrial membrane during diffusion of ⅐NO to or from the cytosol.
Dual effect of ⅐NO on H 2 O 2 Production by Mitochondrial
Membranes-⅐NO elicited a biphasic effect on the production of H 2 O 2 by submitochondrial particles: at concentrations below 3 M, ⅐NO increased H 2 O 2 production, whereas at concentrations above this value, in the range of 3-20 M, ⅐NO decreased mitochondrial H 2 O 2 generation (Fig. 6) . Likewise, ⅐NO exerted a biphasic effect on HO⅐ formation by submitochondrial particles ( Fig. 7) : ⅐NO, at a concentration of 2.5 M, increased the generation of the ␣-hydroxyethyl adduct of 5,5-dimethyl-1-pyrroline-N-oxide by succinate-supplemented submitochondrial particles in a fashion similar to antimycin A (38) . (The ␣-hydroxy-ethyl adduct originates from the HO 2 . mediated H abstraction of ethanol, thereby furnishing evidence for the occurrence of this species; the formation of HO⅐ at this concentration of ⅐NO was further confirmed by the inhibitory effect of catalase (not shown)). At a concentration of 20 M, ⅐NO abolished the electron paramagnetic resonance signal (Fig. 7C) (3, 10) .
The range, a value obtained from a rate of O 2 . production of ϳ1.2 ϫ 10 Ϫ6 M s -1 (calculated from a rate of H 2 O 2 production of ϳ0.13 nmol/min/mg of protein at 2 M . NO in Fig. 6 and a volume for 1 mg of mitochondrial protein of 3.6 l (39, 40)). The above equations may be used to estimate the rate of ONOO -production by mitochondrial membranes as it is affected by varying concentrations of ⅐NO. At the same concentration of ⅐NO utilized for the above calculations (2 ϫ 10 . and the rate of ONOO -formation were plotted for the individual experimental points for H 2 O 2 production in Fig. 6 . The rate of production of ONOO -is slow at low ⅐NO concentrations and when the rate of formation of H 2 O 2 is at its maximum; conversely, as the rate of H 2 O 2 decreases with increasing concentrations of ⅐NO, the rate of ONOO -generation increases. This may strengthen the conclusions drawn from the data in Fig. 7 , in which HO⅐ generationderived from H 2 O 2 scission-by mitochondrial occurs at low ⅐NO concentrations and it switches to ONOO -at high ⅐NO levels. It may also be surmised that the concentration of ⅐NO in the reaction mixture determines the steady-state level of O 2 . . . generated per ONOO -added (Fig. 8A) .
Peroxynitrite as a
Reaction 8 is expected to proceed freely given the reduction potentials of the redox couples involved (E(UQ 2 . /UQH (42, 43) . Additional indirect evidence for the reactivity of peroxynitrite toward ubiquinol may be surmised from the experiments in Fig. 8B : amperometric measurement of ⅐NO in submitochondrial particles supplemented with DETANO (a steady source of ⅐NO) revealed steady-state levels of this species of ϳ0.5 M. Addition of succinate resulted in a decrease of ⅐NO steady-state levels to ϳ0.2 M, whereas the subsequent supplementation of the reaction mixture with superoxide dismutase restored ⅐NO concentration to the initial level (Fig. 8B) . The latter effect suggests ⅐NO utilization via O 2 . (as depicted in Reaction 5) and, hence, formation of ONOO -. Considering the inside-out character of the submitochondrial particles (in which the M side of the mitochondrial inner membrane is exposed to the reaction medium and the electrode), determination of ⅐NO concentration under the conditions of Fig. 8B may model the matrix of intact mitochondria in a manner that ⅐NO electrode is monitoring an expanded mitochondrial matrix. DISCUSSION ⅐NO, produced both by the NOS of the endothelial cells (44) and the mitochondrial NOS in the inner mitochondrial membrane (27) (28) (29) , plays key roles as intracellular and intercellular messenger in the regulation of tissue O 2 uptake and energy production. Endothelium-produced ⅐NO reversibly inhibits cytochrome c oxidase activity and cell O 2 uptake, an action that allows O 2 molecules to further diffuse in the tissue and that decreases the steepness of the O 2 gradient in the normoxia/ anoxia transition (17, 23) . The active production of ⅐NO by the mitochondrial NOS in the inner mitochondrial membrane (at (a) Cytochrome spectra are consistent with a multiple inhibition of the mitochondrial respiratory chain in the presence of ⅐NO, predominantly involving binding of these species to cytochrome oxidase and the cytochrome bc 1 segment. The reaction of ⅐NO with the former probably involves two binding sites (14) : ferrocytochrome a 3 and Cu B ϩ , the latter having a lower affinity for ⅐NO. The inhibition of NADH-and succinate-cytochrome c reductase activities by relatively high concentration of ⅐NO (1.2 ϫ 10 -6 M) (17) suggests that, in addition to the reported effect on cytochrome oxidase (11) , there is a second ⅐NO-sensitive site in the common pathway for both reductases of the electron transfer chain. ⅐NO elicits cytochrome b reduction in the presence of succinate, whereas cytochromes aa 3 and c remain oxidized; this effect indicates inhibition of electron transfer at the O 2 side of cytochrome b (17) in a manner that resembles the effects exerted by antimycin A and myxothiazol.
( . production under physiological conditions and the short half-life of ONOO -(less than 1 s), the intramitochondrial production of this species should remain at relatively low rates (see calculations below).
The ⅐NO-induced inhibition cytochrome bc 1 segment increases the steady-state level of reduced ubiquinone, thereby amplifying the potential of the reaction between UQH 2 and ⅐NO (Reaction 2) (20); a k 2 value of ϳ2 ϫ 10 3 M -1 s -1 may be calculated from the UQ 9 H 2 content in rat mitochondrial membranes.
(c) The steady-state level of ⅐NO in the mitochondrial matrix may be estimated at 5 ϫ 10 -8 M, a mean value derived from the ⅐NO level measured in isolated rat diaphragm (2 ϫ 10 -8 M) (45) , that measured in perfused rat heart stimulated by bradykinin (1 ϫ 10 -7 ) (23), and that calculated for rat liver mitochondria (5 ϫ 10 -8 M) (29 (15) . One of these reductive pathways is sensitive to azide and cyanide and apparently involves reduction of ⅐NO at cytochrome oxidase site (Reaction 4) (15) . The other reductive pathway may be represented by the interaction of ⅐NO with ubiquinol as illustrated in 2 The rate of formation of ONOO -calculated under "Dual Effect of ⅐NO on H 2 O 2 Production by Mitochondrial Membranes" under "Results" was based on the experimental conditions of Fig. 6 , involving a concentration of ⅐NO of 2 ϫ 10 -6 M. . B, amperometric trace of the effect of submitochondrial particles and superoxide dismutase on the steady-state level of ⅐NO. Assay conditions: ⅐NO levels were reached by decomposition of DETANO in respiration medium. Arrow indicates the addition of submitochondrial particles (0.12 mg of protein/ml) and succinate (6 mM). Where indicated, 2 M superoxide dismutase (SOD) was added.
Reaction 2 (20) . The contribution of Reaction 4 (and possibly Reaction 3) to ⅐NO reductive decay is relatively low, and it may be inferred to be ϳ0.04 nmol ⅐NO/min/mg of protein ( Fig. 2A) , although this reaction has not been confirmed with purified cytochrome oxidase (47 (Table I ) are expected to change with the steady-state levels of nitric oxide: for example, under conditions of endothelial NOS activation, ⅐NO levels reach 100 nM in bradykinin-stimulated perfused heart (23) and 470 nM in the diaphragm of lipopolysaccharide-shocked rats (45) . Under these conditions, ONOO -formation may account for as much as 28 and 72%, respectively, of O 2 . utilization. ; 59%) and oxidation of ubiquinol (3.1 ϫ 10 -8 M s -1 ; 36%) and, secondarily, through reduction by cytochrome oxidase and cytochrome c (0.8 ϫ 10 -8 M s -1 ; 5%). The control of mitochondrial functions depends on two variables, ⅐NO and O 2 tension, each one acting on concentration range and gradients and intersecting at critical points. The steady-state level of O 2 in mammalian organs is 5-25 M O 2 , and, especially in heart, 3-8 M (48). These O 2 levels are in a range in which physiological concentrations of ⅐NO (50 -100 nM) define values for the [O 2 ]/[⅐NO] ratios of 50 -100 that experimentally produce 35-15% inhibition of mitochondrial respiration (22) ; under conditions of severe cytochrome oxidase inhibition, the feedback self-regulatory mechanism provided by the initial ubiquinol/⅐NO interaction appears crucial to maintain mitochondrial function. ONOO -seems to be a major product of ⅐NO utilization in aerobiosis: whether ONOO -, formed under these conditions, would elicit oxidative damage in mitochondria would depend on its site of generation (49) , its interception by matrix GSH (50) , and, hypothetically, its reduction by the peroxynitrite reductase activity of mitochondrial glutathione peroxidase (51) .
